Skip to content

Driving Pressure During General Anesthesia for Open Abdominal Surgery

Driving Pressure During General Anesthesia for Open Abdominal Surgery (DESIGNATION) - a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03884543
Acronym
DESIGNATION
Enrollment
1468
Registered
2019-03-21
Start date
2019-04-23
Completion date
2025-06-01
Last updated
2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Respiratory Complication

Keywords

Mechanical ventilation, Positive end-expiratory pressure, Driving pressure, Post-operative postoperative complications, Open abdominal surgery, Recruitment maneuver, PEEP

Brief summary

The purpose of this international multicenter, patient and outcome-assessor blinded randomized controlled trial is to determine whether the application of an individualized high PEEP strategy, aiming at avoiding an increase in the driving pressure during intraoperative ventilation, protects against the development of postoperative pulmonary complications.

Interventions

PROCEDUREIndividualized high PEEP strategy

Patients are randomized and intra-operatively ventilated with an individualized high PEEP strategy (Highest PEEP with the lowest driving pressure with recruitment maneuvers)

Sponsors

Amsterdam UMC, location VUmc
CollaboratorOTHER
Noord West Ziekenhuizen location Alkmaar
CollaboratorUNKNOWN
University Medical Center Groningen
CollaboratorOTHER
Radboud University Medical Center
CollaboratorOTHER
HagaZiekenhuis
CollaboratorOTHER
Rijnstate Hospital
CollaboratorOTHER
Medical Center Haaglanden
CollaboratorOTHER
Bernhoven Hospital
CollaboratorOTHER
Onze Lieve Vrouwe Gasthuis
CollaboratorOTHER
Albert Schweitzer Hospital
CollaboratorOTHER
Frisius Medisch Centrum
CollaboratorOTHER
Leiden University Medical Center
CollaboratorOTHER
Maastricht University Medical Center
CollaboratorOTHER
Martini Hospital Groningen
CollaboratorOTHER
Erasmus Medical Center
CollaboratorOTHER
Spaarne Gasthuis
CollaboratorOTHER
University Hospital Carl Gustav Carus
CollaboratorOTHER
Bermanntrost BG Klinikum Halle
CollaboratorUNKNOWN
Heinrich-Heine University, Duesseldorf
CollaboratorOTHER
Ospedale Policlinico San Martino
CollaboratorOTHER
Jeroen Bosch Ziekenhuis
CollaboratorOTHER
Meander Medical Center
CollaboratorOTHER
Isala
CollaboratorOTHER
Alrijne Hospital
CollaboratorOTHER
Antoni van Leeuwenhoek Ziekenhuis
CollaboratorUNKNOWN
Medisch Spectrum Twente
CollaboratorOTHER
Campus Bio-Medico University
CollaboratorOTHER
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale
CollaboratorNETWORK
University of Roma La Sapienza
CollaboratorOTHER
University of Campania Luigi Vanvitelli
CollaboratorOTHER
Hospital Universitario La Fe
CollaboratorOTHER
Medical University Innsbruck
CollaboratorOTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled for open abdominal surgery * High or intermediate risk for postoperative pulmonary complications according to ARISCAT score \[J.Canet et al, Anesthesiology 2010;113\] * General anesthesia

Exclusion criteria

* Laparoscopic surgery * Surgery in prone or lateral position * Combined procedure with open abdominal and intrathoracic surgery * Body mass index \> 40 kg/m2; * Reported pregnancy; * Mechanical ventilation \> than 30 minutes (e.g., in cases of general anesthesia because of surgery) within last 30 days; * Any major previous lung surgery; * History of previous severe chronic obstructive pulmonary disease (COPD) GOLD III or IV, or with (noninvasive) ventilation and/or oxygen therapy at home; * (previous) acute respiratory distress syndrome (ARDS); * Expected to require postoperative mechanical ventilation; * Persistent hemodynamic instability or intractable shock; * Severe cardiac disease (New York Heart Association class III or IV, or acute coronary syndrome, or persistent ventricular tachyarrhythmia's); * Consented for another interventional study during anesthesia or refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants developing one or more postoperative pulmonary complications (PPCs)The first 5 postoperative daysSevere respiratory failure; ARDS; Suspected pulmonary infection; Pulmonary infiltrate ; Pleural effusion; Atelectasis; Pneumothorax; Bronchospasm; Aspiration pneumonitis; Cardiopulmonary edema

Secondary

MeasureTime frameDescription
Proportion of participants developing one or more post-operative extra-pulmonary complicationsThe first 5 postoperative daysIncluding sepsis (according to the SEPSIS-3 definition), septic shock (defined as sepsis with persisting hypotension requiring vasopressors to maintain MAP ≥ 65mmHg and having a serum lactate level \>2 mmol/L despite adequate volume resuscitation), extra-pulmonary infection (including wound infection and any other infection), anastomic leak and acute renal failure (as defined by AKIN \[Mehta RL., et al., Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care, 2007\])
Rate of intra-operative complicationsFor the length of the anesthesia, which will be estimated 2 to 5 hours.
The total amount and type of intraoperative fluid administrationFor the length of the anesthesia, which will be estimated 2 to 5 hoursType of fluids: colloids, crystalloids or blood products
Rate of mild respiratory failuresThe first 5 postoperative daysDefined as a PaO2 \< 60 mmHg (or \< 7.9 kPa) or SpO2 \< 90% in room air, but responding to supplemental oxygen (excluding hypoventilation)
Length of hospital stayFrom the day of surgery until the day of discharge, up to day 90
Number of participants with an unscheduled Intensive Care Unit (ICU) (re-) admission and length of stay in Intensive care unitFrom the day of surgery until the day of discharged, up to day 90
Assessment of postoperative wound healingThe first 5 postoperative daysVisual inspection of the following: impairment of wound healing and/or wound infection;
Rate of all-cause mortality and in-hospital mortalityPostoperative day 5, day 30 and day 90

Countries

Germany, Italy, Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026